Skip to main content

Table 1 Baseline demographic, anthropometric and clinical data of episodic migraine patients in a randomized controlled trial of vitamin D vs. placebo

From: The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial

 Vitamin D (n = 40)Placebo (n = 40)P value#
Age (year)37 (8)38 (12)0.819
Headache Onset years (year)12 (8)11 (8)0.679
Body mass index (kg/m2)25.83 (4.07)25.36 (4.29)0.613
Sex
 Female32 (80.0%)32 (80.0%)1.000
 Male8 (20.0%)8 (20.0%)
Marital Status
 Married31 (77.5%)26 (65.0%)0.339
 Single9 (22.5%)13 (32.5%)
 Widow/widower0 (0%)1 (2.5%)
Educational Status
 High school13 (32.5%)16 (40.0%)0.293
 BSc11 (27.5%)7 (17.5%)
 MS8 (20.0%)13 (32.5%)
 PhD and higher8 (20.0%)4 (10.0%)
Job
 No job/house wife12 (30.0%)16 (40.0%)0.480
 Student1 (2.5%)3 (7.5%)
 Employee23 (57.5%)17 (42.5%)
 Self employed4 (10.0%)4 (10.0%)
Migraine Aura
 Migraine with aura13 (32.5%)10 (25.0%)0.459
 Migraine without aura27 (67.5%)30 (75.0%)
Familial History of Migraine
 Yes26 (65.0%)32 (80.0%)0.133
 No14 (35.0%)8 (20.0%)
Smoking Status
 No37 (92.5%)35 (87.5%)0.549
 Yes0 (0%)1 (2.5%)
 More than 5 cigarette per week3 (7.5%)4 (10.0%)
 Less than 5 cigarette per week0 (.0%)0 (0%)
  1. Values are expressed as mean (SD) or number (%) as appropriate
  2. #Using either Independent t test or Chi square according to the type of data
\